CNBC·
Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
Summary
- Isomorphic Labs raised a $5 billion Series C round on Tuesday.
- The startup was founded by former Google DeepMind chief Demis Hassabis.
- The funding round was co-led by Greenoaks & Sequoia Capital, with participation from Andreessen Horowitz & Alphabet.
- The capital will support the design & development of new medicines using artificial intelligence.
- Hassabis has served as CEO of Isomorphic Labs since the company spun out of DeepMind in 2021.
- The company is building a proprietary drug design engine & therapeutic candidate pipeline.
- Drug discovery startups raised a record $23.2 billion in 2026 according to Dealroom.
- Isomorphic previously raised $2.1 billion in a Series B round in May.
- Competitors OpenAI & Anthropic have also invested in AI-driven drug discovery tools.
Isomorphic Labs is looking to develop new medicines using AI.
- Keywords
- Breaking News: Technology,Technology,Pharmaceuticals,Demis Hassabis,Alphabet Class A,Novo Nordisk A/S,business news